Ozempic maker now worth more than $500 billion:
axios.com/2024/01/31/novo-profits-jump-wegovy-ozempic
Quick Glance: Novo Nordisk's Value Hits $500 Billion
- Increased demand for effective anti-obesity drugs like Ozempic and Wegovy has propelled Novo Nordisk to reach a market value of over $500 billion on Wednesday, solidifying the Danish company's position as Europe's largest company by market capitalization.
- The company's value exceeds Denmark's entire GDP by over $100 billion, and the GLP-1 drugs could potentially boost sales by up to 26% this year.
- On Wednesday, Novo exceeded earnings estimates and recorded a net profit of 83.7 billion Danish kroner or around $12 billion for 2023.
- In the annual report, the company indicated that sales of its GLP-1 diabetes drugs increased by 52%, with Ozempic generating sales of 95.7 billion Danish kroner or approximately $13.9 billion, and Wegovy sales surpassing 31.3 billion Danish kroner or roughly $4.5 billion.
Story Details
| Last Updated | Feb 01 |
| Total Articles | 28 |
News on this topic
Novo Nordisk says Wegovy is more available after supply boost: Novo Nordisk said it boosted the supply of the lowest dose of its weight loss drug Wegovy ...
nbcnews.com/health/health-news/wegovy-availability-supply-novo-nordisk-weight-loss-rcna136535
Novo Nordisk profit surges as it boosts supplies of Wegovy: Novo Nordisk booked its highest annual profit in decades as the drugmaker said it is increasing ...
washingtonpost.com/business/2024/01/31/novo-nordisk-wegovy-supply-earnings/
Novo Nordisk reported a beat on earnings for the fourth quarter of 2023 as well as for the full year, with total sales up 36% and the company's valuation ... Show more
yhoo.it/3vXBHeR
yhoo.it/3vXBHeR
More articles on this subject
Previous
Novo Nordisk says Wegovy is more available after supply boost: Novo Nordisk said it boosted the supply of the lowest dose of its weight loss drug Wegovy ...
nbcnews.com/health/health-news/wegovy-availability-supply-novo-nordisk-weight-loss-rcna136535
Novo Nordisk profit surges as it boosts supplies of Wegovy: Novo Nordisk booked its highest annual profit in decades as the drugmaker said it is increasing ...
washingtonpost.com/business/2024/01/31/novo-nordisk-wegovy-supply-earnings/
Ozempic maker now worth more than $500 billion: The company has seen an explosion in demand for diabetes and anti-obesity drugs.
axios.com/2024/01/31/novo-profits-jump-wegovy-ozempic
Novo Nordisk (NOVOB) Earnings Surge on Wegovy Frenzy: Novo Nordisk A/S became the second-ever European company to pass $500 billion in market value ...
bloomberg.com/news/articles/2024-01-31/novo-nordisk-smashes-past-500-billion-value-on-wegovy-fervor
Novo Nordisk Beats Profit Forecasts As Weight-Loss Sales Soar: GLP-1 injectable drugs like Ozempic and Wegovy made up a significant portion of the company’s ...
forbes.com/sites/roberthart/2024/01/31/novo-nordisk-beats-profit-forecasts-as-weight-loss-sales-soar/
Novo Nordisk Sees Profit Surging Again Amid Wegovy Rollout: Novo Nordisk A/S said sales and profit will surge again this year as it continues to roll out its ...
trib.al/ERyl69j
slimming injections - how long will the boom at Novo Nordisk last?: The Danish pharmaceutical company Novo Nordisk is reporting phenomenal growth figures thanks ...
wiwo.de/unternehmen/industrie/pharma-abnehmspritzen-wie-lange-haelt-der-boom-bei-novo-nordisk/29629772.html
Obesity Drug WeGovy to Drive Up Profits at Novo Nordisk: Novo Nordisk A/S said sales and profit will surge again this year as it continues to roll out its ...
bloomberg.com/news/articles/2024-01-31/novo-nordisk-sees-profit-surging-again-amid-wegovy-rollout
Paid articlePaid
Danish weight-loss drug maker Novo Nordisk announces blockbuster profits: Danish pharmaceutical giant Novo Nordisk posted bumper profits for 2023 on Wednesday ...
thelocal.dk/20240131/danish-weight-loss-drug-maker-novo-nordisk-announces-blockbuster-profits
Wegovy supply to be more than doubled in US - News | Khaleej Times: Novo Nordisk will ramp up output of lower doses of the obesity drug
khaleejtimes.com/world/americas/wegovy-supply-to-be-more-than-doubled-in-us
Novo Nordisk expects double-digit growth as it boosts Wegovy supplies: Novo Nordisk on Wednesday forecast another year of double-digit sales and operating profit ...
reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-q4-profits-beat-expectations-expects-double-digit-growth-2024-2024-01-31/
Novo Nordisk sees double-digit FY growth; boosts Wegovy supplies to U.S: Novo Nordisk (NOVOb.CO) on Wednesday forecast another year of double-digit record sales ...
reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-q4-profits-beat-expectations-expects-double-digit-growth-2024-2024-01-31/
Drugmaker Novo Nordisk reaches market value of $500 million: Demand for obesity drugs has pushed Novo Nordisk's share price to new highs.
euronews.com/business/2024/01/31/drugmaker-novo-nordisk-reaches-market-value-of-500-million
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars: Novo Nordisk, Europe's largest company by market capitalization, on Wednesday reported ...
cnbc.com/2024/01/31/novo-nordisk-beats-earnings-expectations-as-wegovy-ozempic-demand-soars.html
Novo becomes second ever European firm to breach $500bn market value : Novo Nordisk shares have gained 60 per cent in the past year, fuelled by surging demand ...
businesspost.ie/news/novo-becomes-second-ever-european-firm-to-breach-500bn-market-value/
Paid articlePaid
Novo Nordisk with numbers - will the record run continue?: Novo Nordisk increased sales and profits in 2023, exceeded forecasts and announced a higher dividend ...
deraktionaer.de/artikel/aktien/novo-nordisk-mit-zahlen-geht-die-rekordfahrt-weiter-20349103.html
US Senate committee investigates pricing of Novo's Ozempic and Wegovy: A U.S. Senate committee said on Wednesday it had launched an investigation into the prices ...
reuters.com/business/healthcare-pharmaceuticals/us-senate-committee-investigates-pricing-novos-ozempic-wegovy-2024-04-24/
Plaintiffs' lawyers chosen to lead Ozempic litigation: A federal judge has appointed eight plaintiffs' lawyers to leadership roles in federal mass tort ...
reuters.com/legal/litigation/plaintiffs-lawyers-chosen-lead-ozempic-litigation-2024-04-24/
Medicare beneficiaries could be eligible for Wegovy coverage, study shows
reuters.com/business/healthcare-pharmaceuticals/about-36-mln-medicare-beneficiaries-could-be-eligible-wegovy-coverage-study-2024-04-24/
Zepbound and Mounjaro improve sleep apnea symptoms, Eli Lilly trial shows: A new clinical trial from drugmaker Eli Lilly shows that Zepbound and Mounjaro reduced ...
medicalnewstoday.com/articles/zepbound-mounjaro-improves-sleep-apnea-symptoms
Novo Nordisk may buy German biotech company Cardior: The German biotech company Cardior is researching an active ingredient against heart failure and is now ...
diepresse.com/18385607/novo-nordisk-darf-deutsche-biotech-firma-cardior-kaufen
Bernie Sanders Is Taking on Ozempic’s ‘Astronomically High’ Price Tag: The Vermont senator is launching an investigation into why these game-changing diabetes ...
gizmodo.com/bernie-sanders-investigation-ozempic-high-cost-1851438517
Novo Reigns, Stellantis Resilient: EMEA Earnings Week Ahead: Novo Nordisk A/S’s reign as Europe’s most valuable company “leaves no room to disappoint” with its ...
bloomberg.com/news/articles/2024-04-26/novo-reigns-stellantis-resilient-emea-earnings-week-ahead
Paid articlePaid
Ozempic ‘oops’ babies spark debate about weight-loss shot use as fertility drugs: A surprising thing is happening to some women on weight-loss drugs who’ve ...
bostonherald.com/2024/04/22/ozempic-oops-babies-spark-debate-about-weight-loss-shot-use-as-fertility-drugs/
Medicines Agency: No Ozempic pregnancies in the EU: According to the European Medicines Agency, there are no cases of surprise pregnancies caused by Ozempic in ...
profil.at/wissenschaft/arzneimittelagentur-keine-ozempic-schwangerschaften-in-der-eu/402870968
Is the weight loss injection expensive hype or the big breakthrough?: We talk to doctor Harald Schneider and F.A.Z. editor Lucia Schmidt about the weight loss ...
faz.net/podcasts/f-a-z-podcast-fuer-deutschland/ist-die-abnehmspritze-teurer-hype-oder-der-grosser-durchbruch-19675445.html
Paid articlePaid How one state is trying to make weight loss drugs cheaper: Weight loss drugs aren't covered by insurance for North Carolina's state employees ...
nbcnews.com/health/health-news/one-state-trying-make-weight-loss-drugs-cheaper-rcna148997
Obesity is a complex disease and the stigma around it helps no one: It's important to de-stigmatise obesity as it has many different causes
thenationalnews.com/opinion/comment/2024/04/24/obesity-is-a-complex-disease-and-the-stigma-around-it-helps-no-one/
Run on new weight loss drugs: "Many don't even want their partner to know": Injections from Novo Nordisk and Eli Lilly promise quick slimming on prescription ...
spiegel.de/wirtschaft/unternehmen/wegovy-mounjaro-und-co-kommt-nach-der-abnehmspritze-bald-die-schlankheitspille-a-8d2b1f3f-ec7c-4888-86ae-5494aab96f0e
SHAREHOLDER hot stock Gubra: New arrow against pounds in the quiver: Another source of hope in the Danes' pipeline.
deraktionaer.de/artikel/pharma-biotech/aktionaer-hot-stock-gubra-neuer-pfeil-gegen-pfunde-im-koecher-20355945.html
Paid articlePaid
Equity funds: How SAP makes life difficult for fund managers: The rise of megacaps such as Microsoft, Novo Nordisk and SAP is increasingly becoming a problem for ...
capital.de/geld-versicherungen/aktienfonds--wie-sap-fondsmanagern-das-leben-schwer-macht-34650416.html
Paid articlePaid Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics